Bile-pancreatic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 8554143)

Published in Am J Surg on January 01, 1996

Authors

I Samuel1, R J Joehl

Author Affiliations

1: Department of Surgery, Northwestern University Medical School, Chicago, Illinois 60611-2950, USA.

Articles by these authors

Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology (2001) 2.11

Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery (1999) 1.79

Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology (2000) 1.47

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery (2001) 1.28

Laparoscopic inguinal hernia repair. A preliminary experience. Arch Surg (1993) 1.17

Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch Surg (1991) 1.14

A learning curve for laparoscopic splenectomy at an academic institution. J Surg Res (1999) 1.11

Treatment of anastomotic leakage following low anterior colon resection. Arch Surg (1988) 1.06

One-stage resection and anastomosis in the management of colovesical fistula. Am J Surg (1987) 1.06

Opioid drugs cause bile duct obstruction during hepatobiliary scans. Am J Surg (1984) 1.01

Esophagogastric junction pressure topography after fundoplication. Surgery (2000) 1.01

Impact of fundoplication on bolus transit across esophagogastric junction. Am J Physiol (1998) 1.01

Distinct patterns of oesophageal shortening during primary peristalsis, secondary peristalsis and transient lower oesophageal sphincter relaxation. Neurogastroenterol Motil (2002) 0.99

Rates of morbidity and mortality after closure of loop and end colostomy. Surg Gynecol Obstet (1990) 0.96

Laparoscopic live donor nephrectomy--is it safe? Transplantation (2000) 0.95

Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg (1990) 0.95

Symptomatic malignant melanoma of the gastrointestinal tract. Operative treatment and survival. Ann Surg (1984) 0.92

Reduced tLESR elicitation in response to gastric distension in fundoplication patients. Am J Physiol Gastrointest Liver Physiol (2003) 0.90

External duodenal fistula. Causes, complications, and treatment. Arch Surg (1986) 0.89

Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection. Arch Surg (1983) 0.86

Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats. Am J Surg (1995) 0.86

Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction. J Surg Res (1993) 0.86

The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. JSLS (2011) 0.86

Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg (1995) 0.85

Percutaneous cholecystostomy in the diagnosis and treatment of acute cholecystitis in the high-risk patient. Arch Surg (1989) 0.84

Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery (2000) 0.84

Ligation-induced acute pancreatitis in rats and opossums: a comparative morphologic study of the early phase. J Surg Res (1994) 0.83

Does somatostatin analogue prevent experimental acute pancreatitis? Arch Surg (1990) 0.82

Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis. J Surg Res (1997) 0.81

Cystic neoplasms of the pancreas. J Am Coll Surg (1994) 0.80

Ligation-induced acute pancreatitis increases pancreatic circulating trypsinogen activation peptides. J Surg Res (1996) 0.80

Laparoscopic splenectomy. Surg Clin North Am (1996) 0.80

Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery (1999) 0.80

Hemangioma of the temporalis muscle: a case report and review of the literature. Ann Plast Surg (1979) 0.80

Obstructive jaundice caused by hepatocellular carcinoma. J Surg Oncol (1984) 0.79

Bile exclusion from the gut exacerbates acute pancreatitis caused by pancreatic duct obstruction in rats. Pancreas (1991) 0.79

Esophageal sensitivity and symptom perception in gastroesophageal reflux disease. Curr Gastroenterol Rep (1999) 0.78

Bolus transit assessed by an esophageal stress test in postfundoplication dysphagia. J Surg Res (2000) 0.78

Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis. J Lab Clin Med (1993) 0.78

Acute edematous pancreatitis impairs pancreatic secretion in rats. Surgery (1990) 0.78

Posterior sagittal anorectoplasty for adults. A sphincter-saving operation. Arch Surg (1987) 0.78

Ligation-induced acute pancreatitis in opossums: acinar cell necrosis in the absence of colocalization. J Surg Res (1995) 0.77

Norepinephrine stimulates amylase release from pancreatic acini. J Surg Res (1983) 0.77

Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis. Pancreas (1990) 0.77

Pancreatic polypeptide inhibits amylase release by rat pancreatic acini. J Surg Res (1986) 0.77

Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction. J Surg Res (1993) 0.76

Operative manometry and endoscopy during laparoscopic Heller myotomy. An initial experience. Surg Endosc (1999) 0.76

The effect of glucagon-induced gastric relaxation on TLOSR frequency. Neurogastroenterol Motil (2003) 0.76

Altered gallbladder bile acidification with long-term total parenteral nutrition. J Surg Res (1999) 0.76

A foregut carcinoid tumor causing Zollinger-Ellison syndrome. Arch Surg (1989) 0.75

Characteristics of inhibition of pancreatic secretion by the beta-adrenergic agonist, terbutaline. Pancreas (1986) 0.75

Treatment of peripancreatic fluid collections in patients with complicated acute pancreatitis. Surg Gynecol Obstet (1992) 0.75

Experimental cancer of the bowel in the Nb rat. J Surg Oncol (1983) 0.75

Decreased type IV collagenase activity in experimental pancreatic fibrosis. J Surg Res (2001) 0.75

Inhibition of human pancreatic secretion by terbutaline as a potential agent for treating patients with pancreatic fistula. Surg Gynecol Obstet (1985) 0.75

A new model for study of pancreatic exocrine secretion: the tethered pancreatic fistula rat. Lab Anim Sci (1994) 0.75

Exacerbation of diarrhea after iodinated contrast agents in a patient with VIPoma. Dig Dis Sci (1985) 0.75

Terbutaline inhibits pancreatic secretion. J Surg Res (1981) 0.75

Acute experimental pancreatitis causes prolonged impairment of rat pancreatic secretion. Curr Surg (1990) 0.75

Bilateral adrenal cortical adenomas in primary hyperaldosteronism. Urology (1998) 0.75

Minor wounds in the hemophiliac patient. Pa Med (1977) 0.75

Gastrointestinal tract complications after acute spine injury. Arch Surg (1995) 0.75